Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950149-06-000151
Filing Date
2006-03-31
Accepted
2006-03-31 10:57:21
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f19117e10vk.htm 10-K 862246
2 EXHIBIT 3.2 f19117exv3w2.htm EX-3.2 51853
3 EXHIBIT 23.1 f19117exv23w1.htm EX-23.1 6409
4 EXHIBIT 31.1 f19117exv31w1.htm EX-31.1 8041
5 EXHIBIT 31.2 f19117exv31w2.htm EX-31.2 8000
6 EXHIBIT 32.1 f19117exv32w1.htm EX-32.1 5773
  Complete submission text file 0000950149-06-000151.txt   943810
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
SIRNA THERAPEUTICS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27914 | Film No.: 06725989
SIC: 2834 Pharmaceutical Preparations